Gene · 728655
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes. | Sci Rep | 2023 | 37328616 | PubTator, text mining | PubMed |
| A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection. | EBioMedicine | 2023 | 37315449 | PubTator, text mining | PubMed |
| Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer. | Aging (Albany NY) | 2023 | 37310469 | PubTator, text mining | PubMed |
| Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer. | Sci Rep | 2023 | 37258567 | PubTator, text mining | PubMed |
| MicroRNA-372 acts as a double-edged sword in human cancers. | Heliyon | 2023 | 37251909 | PubTator, text mining | PubMed |
| GATA6 regulates anti-angiogenic properties in human cardiac fibroblasts via modulating LYPD1 expression. | Regen Ther | 2023 | 37251737 | PubTator, text mining | PubMed |
| Emerging role of long non-coding RNA MALAT1 related signaling pathways in the pathogenesis of lung disease. | Front Cell Dev Biol | 2023 | 37250901 | PubTator, text mining | PubMed |
| Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review. | J Cell Mol Med | 2023 | 37246627 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs and Proliferative Retinal Diseases. | Pharmaceutics | 2023 | 37242701 | PubTator, text mining | PubMed |
| lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. | Genes (Basel) | 2023 | 37239411 | PubTator, text mining | PubMed |
| Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing. | Orphanet J Rare Dis | 2023 | 37237386 | PubTator, text mining | PubMed |
| Immune-Related Long Non-Coding RNA Signatures for Tongue Squamous Cell Carcinoma. | Curr Oncol | 2023 | 37232821 | PubTator, text mining | PubMed |
| LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy. | Cancer Med | 2023 | 37212467 | PubTator, text mining | PubMed |
| Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. | Explor Target Antitumor Ther | 2023 | 37205308 | PubTator, text mining | PubMed |
| Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders. | Cells | 2023 | 37190068 | PubTator, text mining | PubMed |
| The Mission of Long Non-Coding RNAs in Human Adult Renal Stem/Progenitor Cells and Renal Diseases. | Cells | 2023 | 37190024 | PubTator, text mining | PubMed |
| Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression. | Int J Mol Sci | 2023 | 37175885 | PubTator, text mining | PubMed |
| Interplay between LncRNAs and microRNAs in Breast Cancer. | Int J Mol Sci | 2023 | 37175800 | PubTator, text mining | PubMed |
| Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. | Cancers (Basel) | 2023 | 37174089 | PubTator, text mining | PubMed |
| Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma. | Discov Oncol | 2023 | 37171645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/728655/papers?page=7